Pearce Catherine 4/A
4/A · CinCor Pharma, Inc. · Filed Jan 13, 2022
Insider Transaction Report
Form 4/AAmended
Pearce Catherine
Chief Operating Officer
Transactions
- Award
Restricted Stock Units
2022-01-12+26,471→ 26,471 total→ Common Stock (26,471 underlying)
Footnotes (3)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
- [F2]This Form 4 amendment is being filed to correct the original Form 4 filed on January 10, 2022. The Transaction Date was stated incorrectly on the original Form 4.
- [F3]The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.